CLINICAL_TRIALS
trial_result
· 2021-02-24
Clinical Trial Update: Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 biomarker trial of everolimus in advanced renal cell carcinoma has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beth Israel Deaconess Medical Center | Conditions: Renal Cell Carcinoma, Renal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-02-24